This content is not available in your region

Patients Go Without Covid-19 Treatments Amid Drug Shortage

Patients Go Without Covid-19 Treatments Amid Drug Shortage
Copyright  Kimberly P. Mitchell/Zuma Press
By Dow Jones & Company

Doctors and patients are trying to figure out how to obtain Covid-19 treatments under a patchwork system set up by states that are directing the distribution of limited supplies.

A shortage of antiviral pills and effective antibody drugs—and difficulties obtaining them—are frustrating efforts to keep Covid-19 patients out of overwhelmed hospitals . States say they are getting a fraction of what they need to meet demand for treatments that can prevent the disease from progressing to the point of hospitalization. That is a concern for some hospitals that are dealing with staffing shortages and a daily crush of sick patients, even as the wave of cases driven by the Omicron wave recedes elsewhere.

Want the whole story?
Read the full article for free on the Wall Street Journal

Continue on WSJ.com